Cardiovascular Network of Canada
CANet is a pan-Canadian organization. Our members are patients, caregivers, investigators, and healthcare providers. We partner with academic institutions, globally recognized industries, not-for-profit organizations, and federal and provincial government agencies.
These unique relationships combine patient engagement, research, digital health advancements, innovation, and commercialization activities to develop and distribute cutting-edge scientific discoveries and technologies to improve patients’ lives and create business opportunities.
Scroll down to see highlights, learn about our impacts, and discover more about our network initiatives.
CANet is one of the many networks that is supported by ACT, which allows CANet Network Investigators to apply for research monies and in-kind support for clinical trials.
To learn more and to apply for available funding opportunities, click here.
CANet has partnered with the Pewaseskwan Indigenous Wellness Research Group (at the University of Saskatchewan) to establish an Indigenous Peoples Engagement and Research Council (IPERC). The council will consist of Indigenous Elders, Knowledge Holders, people with lived/living experience of cardiac conditions, and Indigenous health leaders from various parts of Canada.
Prioritizing Indigenous voices in the research, along with the establishment of the council, CANet will be utilizing its digital health platform, VIRTUES®, as part of its support of heart disease research.
With our vision of patient-driven care for all Canadians, along with ground-breaking CANet-funded research, we continue to assemble innovative digital health technologies.
Apart from VIRTUES, our patient-centred virtual care platform, several of our successful research programs have a global impact. View some of our recent project highlights below. To learn more about all impacts made by our Network, click here.
One of the first programs funded by CANet and the largest clinical trial of its kind, EARLY-AF, found that there was a significantly lower rate of atrial fibrillation recurrence with catheter cryoballoon ablation than with antiarrhythmic drug therapy. The results of this study have recently been published in the New England Journal of Medicine with numerous invited presentations at national/international conferences.
CANet reported the first-ever test flights of drone-delivered AEDs in Canada in simulated mock 9-1-1 responses. The chances of surviving a cardiac arrest decrease by 7 to 10 % for every minute over 10 minutes. This novel, innovative delivery system has significantly reduced the time to AED arrival at the scene of a cardiac arrest from 20 minutes to 10.6 minutes in rural regions.
CANet-funded C-SCAN successfully advocated for a mandatory AED registry in Ontario and helped draft legislation to create a mandatory Provincial AED registry, Bill 141 Defibrillator Registration and Public Access Act, 2020. This legislation received royal assent in June 2020.
as of Mach 2023